Feature
The Period That Came Back
Women type "my period stopped on Ozempic" and "my period came back" in almost equal numbers. Both are real, and the reason is the same one.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
On this page
Two opposite searches, one explanation
Type "ozempic made my period" into Google and watch what it offers to finish: stop. Come back. Late. Lighter. Regular.
Those are contradictory outcomes, suggested with roughly equal confidence, which usually means a search engine is reflecting something genuinely mixed rather than one clean effect. And it is: for a great many women the cycle changes on these drugs, and the direction depends almost entirely on where they started.
None of it is on the labels. What follows is the reported version — the pattern, the mechanism, and the part that catches people out.
The women whose periods came back
This is the better-evidenced direction, and it is not really about the drug.
Weight and ovulation are linked. A systematic review and network meta-analysis compared exercise, diet and pharmacological interventions in reproductive-aged women with overweight or obesity and looked directly at effects on BMI, ovulation and hormonal profile1. Weight reduction moves ovulation.
For women with PCOS the picture is sharper still. A systematic review and meta-analysis of liraglutide — a GLP-1 — in women with PCOS assessed metabolic and reproductive outcomes2, and a 2026 narrative review examines GLP-1 receptor agonists and fertility restoration in women of reproductive age specifically3.
Read plainly: if cycles were irregular or absent because of weight and insulin resistance, losing weight can restart them. That is not a side effect. For some women it is the most significant thing the medication did, and nobody warned them it might.
The women whose periods went strange
The other direction is less studied and more likely to be about the manner of the loss rather than the drug. Rapid weight reduction, low energy intake and the physical stress of a body changing fast can all disturb a cycle. This is old physiology, well described outside GLP-1s, and there is no trial isolating it here.
Which is why "is this the medication?" is usually the wrong question. The more useful one is "is this what my body does when it loses weight quickly?"
★ The part that catches people out
Here is the thing that turns a biology story into an urgent one.
Returning ovulation means returning fertility, and it can return before a period does — ovulation comes first. Women who had spent years assuming they could not easily conceive have found otherwise. The phenomenon has a nickname now, which is how you know it is common.
And the contraception itself may be affected. The prescribing information for tirzepatide instructs patients using oral hormonal contraceptives to switch to a non-oral method, or add a barrier method, for four weeks after starting and for four weeks after each dose increase4. Non-oral hormonal contraception is not affected. Semaglutide's label carries no such instruction.
So on tirzepatide the two things arrive together: fertility potentially returning, and the pill potentially working less well, at exactly the moments the dose is moving. That combination is the single most important paragraph on this page, and it is buried in a document almost nobody reads.
What women told us they wished they had been asked
Not "are you trying to conceive" — the question that would have helped was "what are you using, and is it oral?" Several described being asked the first and not the second.
If your cycle changes on a GLP-1, it is worth raising rather than filing under side effects to be endured — because a returning cycle may be good news, a disappearing one deserves a look, and the contraception question has a different answer depending on which molecule you are taking.
Frequently asked questions
Can a GLP-1 make your period come back?
Yes, and for some women it is the most significant thing the medication does. Weight reduction is linked to returning ovulation — a network meta-analysis of interventions in reproductive-aged women with overweight or obesity examined exactly that — and in PCOS the reproductive effects of a GLP-1 have been assessed in a systematic review and meta-analysis. If cycles were irregular because of weight and insulin resistance, losing weight can restart them.
Why did my period stop or go irregular instead?
That direction is less studied and is more likely about how the weight came off than about the drug. Rapid weight reduction, low energy intake and the physical stress of a fast-changing body can all disturb a cycle — physiology well described outside GLP-1s, with no trial isolating it here. The more useful question is what your body does when it loses weight quickly.
Does a returning cycle mean I could get pregnant?
Yes, and ovulation returns before a period does, so fertility can come back before there is any visible sign. Separately, the tirzepatide labels instruct patients on ORAL hormonal contraceptives to switch to a non-oral method or add a barrier method for four weeks after starting and for four weeks after each dose increase. Non-oral hormonal methods are not affected, and semaglutide's label carries no equivalent instruction.
References
- Ruiz-González D, Cavero-Redondo I, Hernández-Martínez A, et al. (2024). Comparative efficacy of exercise, diet and/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis. Human Reproduction Update. https://pubmed.ncbi.nlm.nih.gov/38627233/
- Lu YT, Chang PH, Chen HJ, et al. (2026). Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/41508932/
- Abedi MM, Patni MM, Shajahan ANB, et al. (2026). GLP-1 Receptor Agonists, Fertility Restoration, and Reproductive Safety in Women of Reproductive Age: A Narrative Review. Journal of Clinical Medicine. https://pubmed.ncbi.nlm.nih.gov/42122936/
- U.S. Food and Drug Administration (2025). Zepbound (tirzepatide) injection — Prescribing Information (switch from oral hormonal contraceptives or add a barrier method for 4 weeks after initiation and after each dose escalation). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
Reported, not prescribed. Everything on this page is journalism and general education — not a diagnosis, a treatment plan, or a recommendation to start or stop any medication. Your history, hormones, and pregnancy plans are yours alone; only a licensed clinician who knows them can advise you. Talk to one before you act on anything you read here.
Continue reading
GLP-1s and PCOS: The Evidence, the Hype, and What It Means for You
GLP-1s reliably help the metabolic side of PCOS — weight, insulin resistance. The androgen and ovulation story is more mixed. An honest, evidence-first read.
ReadPerimenopause, Appetite, and Where a GLP-1 Fits
The hunger and body changes of your forties are not a character flaw. On perimenopause, shifting body composition, and where a GLP-1 actually fits.
ReadGLP-1s and Birth Control: The Warning Nobody Reads Aloud
Tirzepatide (Zepbound) can make the pill less reliable — the FDA label says so. What it means, why semaglutide differs, and what to do.
Read